VisionGate Raises $2M For Lung Cancer Diagnostics
Phoenix-based VisionGate, a developer of non-invasive test for the early detection of lung cancer, said today that it has raised $2M in a first tranche of a financing round. According to the firm, the funding comes as part of an ongoing $3M funding round, and came from both new and existing investors. Names of the investors in the round were not announced.
posted on Wednesday, October 19, 2011 (Link to more information)
Related companies:
Visiongate
Related stories:
> VisionGate Claims Advance
> Biodesix Brings Series E To $14.4M
> Biodesix Scores $7.1M For Lung Cancer Tests
> Provista Diagnostics Raises $5.0M
> Provista Diagnostics Raises $6.0M
Techrockies.com Home